A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer
Clinical trial NCT03471663 · COMPLETED
Trial details
- NCT number
- NCT03471663
- Sponsor
- InventisBio Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-18
- Primary completion
- 2023-10-18
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.